icon-folder.gif   Conference Reports for NATAP  
 
  65th Annual Meeting of the
American Association for the
Study of Liver Diseases
Boston, MA Nov 7-11 2014
Back grey_arrow_rt.gif
 
 
 
HBsAg Loss With Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a in Chronic Hepatitis B: Results of a Global Randomized Controlled Trial
 
 
  Reported by Jules Levin
AASLD 2014 Nov 7-11 Boston
 
Patrick Marcellin1, Sang-Hoon Ahn2, Xiaoli Ma3, Florin A. Caruntu4, Won-Young Tak5, Magdy Elkashab6, Wan-Long Chuang7, Fehmi Tabak8, Rajiv Mehta9, Joerg Petersen10, Eduardo B. Martins11, Phillip Dinh11, Amoreena Corsa11, Prista Charuworn11, G. Mani Subramanian11, John G. McHutchison11, Maria Buti12, Giovanni Gaeta13, George Papatheodoridis14, Robert Flisiak15, Henry L.Y. Chan16 1Hôpital Beaujon, Université Paris-Diderot, Clichy, France; 2Yonsei University College of Medicine, Seoul, South Korea; 3Drexel University College of Medicine, Philadelphia, PA; 4National Institute for Infectious Diseases "Prof Dr Matei Bals," Bucharest, Romania; 5Kyungpook National University Hospital, Daegu, South Korea; 6Toronto Liver Centre, Ontario, Canada; 7Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan; 8Istanbul University Cerrahpasa Faculty of Medicine, Istanbul, Turkey; 9Liver Clinic, Surat, India; 10University of Hamburg, Germany; 11Gilead Sciences Inc., Foster City, CA; 12Hospital Universitari Vall d'Hebron, Barcelona, Spain; 13Second University of Naples, Italy; 14Athens University Medical School, Athens, Greece; 15Medical University of Bialystok, Poland; 16The Chinese University of Hong Kong, Hong Kong SAR, Peoples Republic of China

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif

AASLD9.gif

AASLD10.gif

AASLD11.gif

AASLD12.gif

AASLD13.gif